ClinicalTrials.gov
ClinicalTrials.gov Menu

Preventing Intimate-partner Violence: Impact Evaluation of Engaging Men Through Accountable Practice in Eastern DRC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02765139
Recruitment Status : Completed
First Posted : May 6, 2016
Last Update Posted : May 21, 2018
Sponsor:
Collaborator:
International Rescue Committee
Information provided by (Responsible Party):
World Bank

Brief Summary:
The objective of the study is to evaluate the impact of Engaging Men in Accountable Practice (EMAP) on the prevention of violence against women and girls in North and South Kivu (DRC). The study is conducted jointly by the World Bank's Africa Gender Innovation Lab and the International Rescue Committee (IRC). EMAP is a program developed and implemented by the IRC to engage men to reflect on how to reduce and prevent intimate partner violence through 16 weekly group discussion sessions. The study is a cluster randomized control trial in which two groups of 25 self-selected men in 15 communities receive the EMAP intervention while in 15 other communities, 50 self-selected men receive an alternative intervention. Key outcomes examined include: (i) Experience of past year physical, sexual and psychological violence reported by women whose partners are EMAP participants; (ii) Participant's gender attitudes and behaviors, conflict and hostility management skills; (iii) Power sharing and communication within the couple.

Condition or disease Intervention/treatment Phase
Intimate Partner Violence Domestic Violence Family Relations Behavioral: Engaging Men through Accountable Practice Other: Alternative intervention Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 1387 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Preventing Intimate-partner Violence: Impact Evaluation of Engaging Men Through Accountable Practice in Eastern DRC
Study Start Date : February 2016
Actual Primary Completion Date : December 2017
Actual Study Completion Date : December 2017

Arm Intervention/treatment
Experimental: EMAP Treatment
Engaging Men through Accountable Practice: 30 communities are matched into 15 pairs on a set of socio-demographic characteristic and within each pair, 15 treatment sites are randomly selected. Within each treatment community, all adult men (20+ years old) are eligible to participate in the EMAP intervention. A random draw of 50 participants determines who will participate in EMAP in case more than 50 eligible men express interest.
Behavioral: Engaging Men through Accountable Practice
Engaging Men through Accountable Practice aims to engage men as agents of change through structured, weekly discussions with committed groups of men. It aims to address entrenched views of gender roles and identify positive models of masculinity. The approach follows a structured series of discussions designed to explore existing understandings of masculinity and create more positive models of what it means to be a 'good' man, promoting self-reflection and pushing men to analyze and change their own power and privilege. This methodology begins with a series of discussions with women to inform men's dialogue groups, and includes continuous feedback loops with women throughout the process so that the work with men is grounded in, and accountable to, women's views and objectives.

Control
In the 15 control sites, the male participants will receive an alternative intervention focused on a non-gender topic of 16 weekly sessions for men only.
Other: Alternative intervention
Control communities will receive an alternative intervention focused on a non-gender topic of 16 weekly sessions for men only.




Primary Outcome Measures :
  1. Change in baseline prevalence of intimate-partner violence [ Time Frame: Baseline, 12 months follow-up ]
    Change in the % of women who self-report experience of violence by their male partner. The women interviewed are the partners of the male study participants.


Secondary Outcome Measures :
  1. Change in acceptability of intimate partner violence [ Time Frame: Baseline, 12 months follow-up ]
    Change in the % of women (partners of participants) and men (participants) who report that violence is acceptable in at least one of the situations listed in the survey.

  2. Change in intention to commit violence [ Time Frame: Baseline, 12 months follow-up ]
    Change in the % of male participants who report that they are likely to become violent in a list of situations. Scale used: Proximal Antecedents to Violent Episodes.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Age 20 or older but preferably at least 25;
  • Resident of their village, having lived in the community for a minimum of six months with plans to continue living there for at least the coming six months;
  • Ability to participate actively in group work and reflection activities;
  • Commitment to attend meetings, sessions and other activities regularly without incentives;
  • Commitment to non-violence toward women and girls for the duration of the EMAP intervention;

Exclusion Criteria:

  • Involved in the IRC-led adolescent girl intervention (COMPASS).

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02765139


Locations
Congo, The Democratic Republic of the
International Rescue Committee
Bukavu, Congo, The Democratic Republic of the
International Rescue Committee
Goma, Congo, The Democratic Republic of the
Sponsors and Collaborators
World Bank
International Rescue Committee
Investigators
Principal Investigator: Julia Vaillant, PhD World Bank

Responsible Party: World Bank
ClinicalTrials.gov Identifier: NCT02765139     History of Changes
Other Study ID Numbers: P149394
First Posted: May 6, 2016    Key Record Dates
Last Update Posted: May 21, 2018
Last Verified: May 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: The World Bank has an open data policy, and the de-identified, anonymized data will be published online after the study is completed.

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No